WebGenerating Revenue. 4. Later Stage VC. 02-Mar-2011. $1M. $3.3M. Completed. Generating Revenue. To view Cytonics’s complete valuation and funding history, request access ».
Did you know?
WebCytokinetics, Incorporated CYTK: Raising target price to $38.00 CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $38.000000; an Industry Subrating of … Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo … See the company profile for Cytokinetics, Incorporated (CYTK) including business … View the basic CYTK option chain and compare options of Cytokinetics, … NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend … NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio … Find out all the key statistics for Cytokinetics, Incorporated (CYTK), … Get the detailed quarterly/annual income statement for Cytokinetics, Incorporated … Find out the direct holders, institutional holders and mutual fund holders for … See Cytokinetics, Incorporated (CYTK) Environment, Social and Governance … WebMar 31, 2024 · CYTK: Get the latest Cytokinetics stock price and detailed information including CYTK news, historical charts and realtime prices. Menu icon A vertical stack of …
WebMar 31, 2024 · On Friday 03/31/2024 the closing price of the Cytokinetics Inc share was $35.19 on NAS. Compared to the opening price on Friday 03/31/2024 on NAS of $35.02, this is a gain of 0.48%. WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate
Web18 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has …
WebStock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebGet the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … high net worth liability insuranceWebSep 23, 2024 · SOUTH SAN FRANCISCO, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants have been dosed in a Phase 1 placebo ... how many acres in osage county oklahomaWebApr 11, 2024 · The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00. Do Wall Street analysts like … how many acres in wvWebAug 8, 2024 · For example, the Cytokinetics, Incorporated (NASDAQ:CYTK) share price is up a whopping 327% in the last half decade, a handsome return for long term holders. If that doesn't get you thinking about ... high net worth investment opportunitiesWebFeb 28, 2024 · In fact, the Most Accurate Estimate for the current quarter is currently at a loss of $1.18 per share for CYTK, compared to a broader Zacks Consensus Estimate of a loss of $1.22 per share. how many acres is 1 000 square feetWebNov 8, 2024 · The cap price of the capped call transactions will initially be approximately $14.07 per share, which represents a premium of approximately 70% over the per share closing price of Cytokinetics’s ... high net worth money managersWebApr 6, 2024 · A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. high net worth networking